Behavior and Naltrexone Treatment for Alcoholics
Launched by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) · Nov 2, 1999
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Meets criteria for alcohol dependence.
- Exclusion Criteria:
- • Current diagnosis of dependence on other substances except nicotine.
- • A history of psychosis or current psychotic symptoms.
- • Current suicidality, homocidality, or psychiatric symptoms that require additional medication.
- • Current use of disulfiram (Antabuse).
- • Evidence of significant cerebral, renal, thyroid, or cardiac disease.
- • History of opioid abuse in the previous year.
- • History of cirrhosis, hepatocellular disease, or elevated bilirubin.
- • Females who are pregnant, nursing, or not using a reliable method of birth control.
About National Institute On Alcohol Abuse And Alcoholism (Niaaa)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is a leading federal agency dedicated to advancing research on alcohol-related health issues and fostering a deeper understanding of alcohol use disorders. As part of the National Institutes of Health (NIH), NIAAA supports a diverse portfolio of clinical trials aimed at developing innovative prevention and treatment strategies for alcohol abuse and dependence. By collaborating with researchers, healthcare providers, and community organizations, NIAAA strives to translate scientific findings into effective public health initiatives, ultimately aiming to reduce the impact of alcohol on individuals and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials